Dr. Libby Buscemi, MD

Dr. Buscemi practices at Libby Buscemi, MD in New York, New York.

Dr. Buscemi's NPI, 1710044599, was assigned on January 2, 2007. Dr. Buscemi graduated from New York Medical College in 1996. Dr. Buscemi holds New York license 212372.

Dr. Buscemi's primary practice is Libby Buscemi, MD, at 176 E 71st St, New York, NY 10021 in New York County. The practice phone is (212) 734-7546.

Dr. Buscemi's primary practice is Libby Buscemi, MD in New York, New York. The medical group on file is Libby Buscemi MD PC. Dmand AI also links Dr. Buscemi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buscemi practices. Vendor and product names are available with a free account.

Dermatology is Dr. Buscemi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Buscemi is board certified in dermatology by the American Board of Dermatology. Dr. Buscemi is licensed in New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Buscemi treats.

CMS data shows 4,573 Medicare services from Dr. Buscemi across 27 procedure codes in 2024, for 916 Medicare patients. Medicare paid $272,177 for them. Every service was in an office.

CMS counts 916 Medicare patients who saw Dr. Buscemi in 2024. The largest group is 75 to 84, with 426 patients. 75% of them have high cholesterol, and 58% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Buscemi's median patient age at 61, with 63% women.

In 2024, Dr. Buscemi wrote 792 Medicare Part D claims for 381 patients. 93% of them were for generic drugs. CMS names the drug for 655 of them, across 18 drugs with 11 or more claims each, at $15,105 in total drug cost. In 2023, CMS named 654 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Buscemi for performance year 2024, reported as part of a group. Dr. Buscemi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 817 procedures of skin biopsy by Dr. Buscemi, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 368 general payments to Dr. Buscemi from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Bausch Health Americas, Inc. paid the most, $1,031.

Dmand AI lists 1 award for Dr. Buscemi, most recently CMS Stage 1 EHR in 2013.

Dr. Buscemi graduated from New York Medical College in 1996.

Dr. Buscemi is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.